DexCom Inc (DXCM)

Days of sales outstanding (DSO)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Receivables turnover		3.65	4.29	4.20	4.60	3.84	4.59	4.25	4.55	4.54	4.17	4.26	4.32	4.26	4.74	5.60	5.17	4.98	5.54	5.46	5.42
DSO	days	100.03	85.13	86.85	79.34	95.03	79.53	85.93	80.20	80.44	87.52	85.74	84.54	85.75	76.97	65.20	70.58	73.24	65.85	66.79	67.40

December 31, 2023 calculation

DSO = 365 ÷ Receivables turnover
= 365 ÷ 3.65
= 100.03

Dexcom Inc's days of sales outstanding (DSO) have shown fluctuations over the past quarters. In Q4 2023, the DSO was 99.51 days, which increased compared to the previous quarter's 84.57 days. This indicates that it took Dexcom Inc longer to collect its accounts receivable in the most recent quarter. However, the DSO in Q4 2023 was still lower than the DSO in Q4 2022, which was 94.35 days.

Overall, Dexcom Inc's DSO has generally been hovering around the 80-90 day range in the past several quarters, indicating that the company typically takes around 80-90 days to collect its accounts receivable. It is important for Dexcom Inc to actively manage its DSO to ensure timely collection of receivables and maintain healthy cash flows.